Diurnal Group plc announced the appointment of Richard Bungay as Chief Financial Officer (CFO), effective January 16, 2017. Richard succeeds Ian Ardill who has given notice of his resignation as the company's CFO in order to pursue other business opportunities. Ian will leave Diurnal on 13 January 2017 and will be available to support an orderly handover. Mr. Bungay has over 20 years' experience in corporate roles within R&D-based companies within the biotechnology and pharmaceutical sector, including as CFO of both public and private companies, with a particular focus on financing, investor relations and business development. Most recently, Richard has been CFO and Chief Operating Officer of Mereo BioPharma Group plc.